Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Pharma
Pharma
Regulatory tracker: Takeda's cancer med nabs FDA priority review
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Kevin Dunleavy
May 26, 2023 12:05pm
EU regulators recommend pulling Novartis sickle cell med Adakveo
May 26, 2023 11:18am
AZ's Imfinzi-Lynparza combo adds endometrial cancer trial win
May 26, 2023 10:28am
Pfizer, BioNTech to cut vax supply to EU, Moderna woos China
May 26, 2023 9:51am
Gilead, Teva reach last-minute settlements in HIV antitrust case
May 26, 2023 9:50am
Carvykti, Thermo Fisher, Celltrion—Fierce Pharma Asia
May 26, 2023 9:40am
